Gary Ingenito, Chief Medical Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 150,000 shares at $4.82 ($723K) on 2019-12-05, disclosed to the SEC on 2019-12-06.
Open-market sale of $723k CPRX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CPRX | SELL | 2024-11-29 | $545K | — | Filing → |
| CPRX | SELL | 2024-11-22 | $806K | — | Filing → |
| CPRX | SELL | 2024-08-13 | $1.8M | — | Filing → |